Join us for our two part Science Series, designed specifically for in-house lawyers working within life sciences companies. This unique programme aims to bridge the gap between legal expertise and scientific innovation, providing lawyers with user-friendly overview of the science underlying some cutting-edge technologies.

Each session will give an overview of the science and explanation of the jargon, followed by related legal considerations. Aimed at those who would like to deepen their understanding of the scientific principles driving their company's technological advancements - whether you are new to the field or looking to refresh your knowledge.

Oncolytic viruses and cancer vaccines are emerging as promising treatments in oncology. Oncolytic viruses selectively infect and destroy cancer cells, while therapeutic cancer vaccines stimulate the adaptative immune system against specific malignant cells so the immune system can destroy them. There is growing interest in their potential to complement traditional therapies like surgery, chemotherapy, and radiation.

In this session, Bristows will delve into the science behind oncolytic viruses and therapeutic cancer vaccines, exploring their mechanisms and applications, along with some legal considerations relevant to these technologies.